Over-Expression of DSCR1 Protects against Post-Ischemic Neuronal Injury

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Brait, Vanessa H ^a   Martin, Katherine R ^a   Corlett, Alicia ^a   Broughton, Brad R S ^a   Kim, Hyun Ah ^a   Thundyil, John ^b   Drummond, Grant R ^a   Arumugam, Thiruma V ^b   Pritchard, Melanie A ^a   Sobey, Christopher G ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CHROMOSOME PROTEIN; CYCLOOXYGENASE 2; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; DOWN SYNDROME CANDIDATE REGION 1 PROTEIN; GLUCOSE; INTERLEUKIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME CANDIDATE REGION 1 GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENOTYPE; GRIP STRENGTH; HIPPOCAMPUS; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; APOPTOSIS; BRAIN; BRAIN INFARCTION; BRAIN INJURIES; CELLS, CULTURED; CYTOKINES; EDEMA; GENE EXPRESSION; GLUCOSE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MUSCLE PROTEINS; NEUTROPHIL INFILTRATION; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

MUS;

EID: 84868121907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047841     Document Type: Article

References (38)

1. Donnan GA, Fisher M, Macleod M, Davis SM, (2008) Stroke. Lancet 371: 1612-1623.
2. Barker-Collo S, Starkey N, Lawes CM, Feigin V, Senior H, et al. (2012) Neuropsychological profiles of 5-year ischemic stroke survivors by Oxfordshire stroke classification and hemisphere of lesion. Stroke 43: 50-55.
3. Brouns R, De Deyn PP, (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111: 483-495.
4. Wang Q, Tang XN, Yenari MA, (2007) The inflammatory response in stroke. J Neuroimmunol 184: 53-68.
5. Davies KJ, Ermak G, Rothermel BA, Pritchard M, Heitman J, et al. (2007) Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 21: 3023-3028.
6. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, et al. (1995) A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Human molecular genetics 4: 1935-1944.
7. Ermak G, Morgan TE, Davies KJ, (2001) Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. The Journal of biological chemistry 276: 38787-38794.
8. Fuentes JJ, Pritchard MA, Estivill X, (1997) Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44: 358-361.
9. Porta S, Marti E, de la Luna S, Arbones ML, (2007) Differential expression of members of the RCAN family of calcineurin regulators suggests selective functions for these proteins in the brain. The European journal of neuroscience 26: 1213-1226.
10. Ermak G, Harris CD, Davies KJ, (2002) The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 16: 814-824.
11. Leahy KP, Crawford DR, (2000) adapt78 protects cells against stress damage and suppresses cell growth. Archives of biochemistry and biophysics 379: 221-228.
12. Crawford DR, Leahy KP, Abramova N, Lan L, Wang Y, et al. (1997) Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. Archives of biochemistry and biophysics 342: 6-12.
13. Cho KO, Kim YS, Cho YJ, Kim SY, (2008) Upregulation of DSCR1 (RCAN1 or Adapt78) in the peri-infarct cortex after experimental stroke. Experimental neurology 212: 85-92.
14. Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, et al. (2012) Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury. Journal of neuroinflammation 9: 48.
15. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, et al. (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. The Journal of biological chemistry 275: 8719-8725.
16. Hogan PG, Chen L, Nardone J, Rao A, (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes & development 17: 2205-2232.
17. Kim YS, Cho KO, Lee HJ, Kim SY, Sato Y, et al. (2006) Down syndrome candidate region 1 increases the stability of the IkappaBalpha protein: implications for its anti-inflammatory effects. The Journal of biological chemistry 281: 39051-39061.
18. Brait VH, Arumugam TV, Drummond GR, Sobey CG, (2012) Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 32: 598-611.
19. Keating DJ, Dubach D, Zanin MP, Yu Y, Martin K, et al. (2008) DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease. Human molecular genetics 17: 1020-1030.
20. Brait VH, Jackman KA, Walduck AK, Selemidis S, Diep H, et al. (2010) Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 30: 1306-1317.
21. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME, (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. The Journal of neuroscience: the official journal of the Society for Neuroscience 17: 9157-9164.
22. Hattori K, Lee H, Hurn PD, Crain BJ, Traystman RJ, et al. (2000) Cognitive deficits after focal cerebral ischemia in mice. Stroke; a journal of cerebral circulation 31: 1939-1944.
23. Basu A, Lazovic J, Krady JK, Mauger DT, Rothstein RP, et al. (2005) Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 25: 17-29.
24. Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, et al. (2007) Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proceedings of the National Academy of Sciences of the United States of America 104: 14104-14109.
25. Thundyil J, Tang SC, Okun E, Shah K, Karamyan VT, et al. (2010) Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Experimental & translational stroke medicine 2: 15.
26. Jin R, Yang G, Li G, (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87: 779-789.
27. Kirino T, (2000) Delayed neuronal death. Neuropathology: official journal of the Japanese Society of Neuropathology 20 Suppl: S95-97.
28. Mehta SL, Manhas N, Raghubir R, (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain research reviews 54: 34-66.
29. Emsley HC, Tyrrell PJ, (2002) Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 22: 1399-1419.
30. Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, et al. (1995) Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26: 1438-1442 discussion 1443.
31. Zhang RL, Chopp M, Li Y, Zaloga C, Jiang N, et al. (1994) Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44: 1747-1751.
32. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, et al. (1994) Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 25: 1469-1475.
33. Matsuo Y, Onodera H, Shiga Y, Shozuhara H, Ninomiya M, et al. (1994) Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res 656: 344-352.
34. Yenari MA, Kunis D, Sun GH, Onley D, Watson L, et al. (1998) Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia. Exp Neurol 153: 223-233.
35. Asai A, Qiu J, Narita Y, Chi S, Saito N, et al. (1999) High level calcineurin activity predisposes neuronal cells to apoptosis. The Journal of biological chemistry 274: 34450-34458.
36. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, et al. (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126-1130.
37. Martin KRC, Dubach A, Mustafa D, Coleman T, Parkington HA, Merson HC, Bourne TD, Porta JA, Arbonés S, Finkelstein ML, (2012) Pritchard MA, (2012) Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory. Hum Mol Genet 21: 3025-3141.
38. Jea ASE, Robertson R, Scott RM, (2005) Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics 116: e694-701.